The global veterinary therapeutics market share is expected to witness significant growth in the coming years. This can be attributed to several factors such as the increasing prevalence of animal diseases, rising pet adoption rates, and growing awareness about animal health.

One of the key drivers for the market is the rising demand for effective treatments for various animal diseases. With the increasing incidence of diseases like zoonotic infections, respiratory disorders, and gastrointestinal problems in animals, there is a growing need for advanced therapeutics to ensure their well-being. This has led to a surge in research and development activities by pharmaceutical companies to develop innovative drugs and therapies specifically designed for animals.

Moreover, the growing trend of pet ownership across the globe has also contributed to the expansion of the veterinary therapeutics market. As more people consider pets as part of their family, they are willing to invest in their healthcare needs. This has resulted in an increased demand for preventive medications, vaccines, and other therapeutic products.

The Veterinary Therapeutics Market size was assessed at USD 31.54 billion in 2022 and is supposed to develop at a build yearly development rate (CAGR) of 7.3% from 2023 to 2030, and is expected to reach USD 55.42 billion by 2030.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1082

KEY MARKET SEGMENTATION:

By Type

• Anti-inflammatory
• Parasiticides
• Other

By Application

• Hospitals
• Veterinary Clinic
• Drug Stores
• Others

Some of the major key players are as follows: Bayer AG., Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Eli Lilly and Company (Elanco Animal Health), Merck Animal Health, Sanofi (Merial Animal Health), Virbac, Vetoquinol S.A., Zoeti and Other Players.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com